Big Data Analysis and Artificial Intelligence for Medical Sciences

List of Contributors xiii

Preface xix

1 Introduction 1
Bruno Carpentieri and Paola Lecca

1.1 Disease Diagnoses 4

1.2 Drug Development 6

1.3 Personalized Medicine 6

1.4 Gene Editing 7

Author Biographies 9

References 9

2 Fuzzy Logic for Knowledge-Driven and Data-Driven Modeling in Biomedical Sciences 17
Paolo Cazzaniga, Simone Spolaor, Caro Fuchs, Marco S. Nobile and Daniela Besozzi

2.1 Introduction 17

2.2 Fuzzy Logic 18

2.2.1 Fuzzy Sets 19

2.2.2 Linguistic Variables 19

2.2.3 Fuzzy Rules 20

2.2.4 Fuzzy Inference Systems 21

2.2.5 Simpful 22

2.3 Knowledge-Driven Modeling 22

2.3.1 Dynamic Fuzzy Modeling 23

2.3.2 Application 1: Maximizing Cancer Cells Death with Minimal Drug Combinations 25

2.3.3 FuzzX: A Hybrid Mechanistic-Fuzzy Modeling and Simulation Engine 27

2.3.4 Application 2: Analyzing Oscillatory Regimes in Signal Transduction Pathways 29

2.4 Data-Driven Modeling 30

2.4.1 pyFUME: Automatic Generation of Fuzzy Inference Systems 31

2.4.2 Application 3: Assessing Tremor Severity in Neurological Disorders 33

2.5 Discussion 35

Author Biographies 36

References 37

3 Application of Machine Learning Algorithms to Diagnosis and Prognosis of Chronic Wounds 43
Mai Dabas and Amit Gefen

3.1 Background 43

3.1.1 Chronic Wounds 43

3.1.2 Implementation of AI Methodologies in Wound Care and Management 43

3.2 Clinical Visual Assessment of Wounds Supported by Artificial Intelligence 44

3.2.1 Predicting the Formation and Progress of Wounds Based on Electronic Health Records 46

3.2.2 Predicting the Formation and Evolution of Wounds Based on a Dynamic Evaluation of Wound Characteristics and Relevant Physiological Measures 48

3.2.3 Feasible Implementation of AI Solutions For Wound Care Delivery and Management 49

3.2.4 Types of Data Modalities for Diagnosis, Detection, and Prediction of Chronic Wounds 50

3.3 Smartphone and Tablet Use in Wound Diagnosis and Management 51

3.4 Conclusions 53

Acronyms 54

Author Biographies 55

References 55

4 Deep Learning Techniques for Gene Identification in Cancer Prevention 59
Eleonora Lusito

4.1 The Next-Generation Era of Cancer Investigation 59

4.1.1 Cancer at Its First Definitions 59

4.1.2 Attempts to Sequence Nucleic Acids Over the Years 60

4.1.3 From the First to the Third-Generation Sequencing 61

4.1.4 Applications of NGS in Clinical Oncology 62

4.2 Deep Learning Approaches for Genomic Variants Identification in Cancer 63

4.2.1 Cancer Causing Factors 63

4.2.2 The Contribution of Germline Alterations to Cancer 64

4.2.3 Somatic Mutations and Cancer 64

4.2.4 Calling Variants from Sequence Data 65

4.2.5 Computational Approaches for Variant Discovery 65

4.2.6 Convolutional Neural Networks (CNNs): Basic Principles 66

4.2.7 Application of CNNs to Variant Calling 67

4.2.8 A Typical CNN Architecture for Variant Calling 68

4.2.9 The Activation Function 69

4.2.10 Dropout and L1–L2 Regularization 71

4.2.11 Advantages of Deep Learning Over the Existing Techniques 72

4.2.12 Residual Neural Networks (ResNet)-Inspired CNN in Genomic Variants Detection 73

4.3 Deep Learning in Cancer Transcriptomics 74

4.3.1 Gene Expression and Cancer 74

4.3.2 Analytical Approaches to Deal with Gene Expression Data 76

4.3.3 Stacked Denoising Autoencoders (SDAEs) for Dimensionality Reduction 76

4.3.4 The Variational Autoencoder (VAE) 79

4.3.5 VAEs to Integrate Gene Expression and Methylation Data 81

4.3.5.1 DNA Methylation: the Epigenetic Regulation of Gene Expression 81

4.3.5.2 Preprocessing Input Data of Different Sources 82

4.3.5.3 A VAE Architecture for Multimodal Data 82

4.4 Conclusions 84

Acronyms 86

Author Biographies 87

References 87

5 Deep Learning for Network Biology 97
Eleonora Lusito

5.1 Types of Interactions Between Genes and Their Products 97

5.2 Deep Learning Methods with Graph-input Data 99

5.2.1 Graph Embedding 99

5.2.1.1 Random Walk-Based Graph Embedding 100

5.2.1.2 Proximity-Based Graph Embedding 101

5.2.2 Graph Convolutional Networks (GCNs) 102

5.3 Applications of GNNs to Infer Biological and Pharmacological Interactions 104

5.3.1 Proteomics 104

5.3.2 Drug Development and Repurposing 104

5.3.3 Drug–Drug Interaction Prediction 105

5.3.4 Disease Classification and Outcome Prediction 106

Author Biography 107

References 107

6 Deep Learning-Based Reduced Order Models for Cardiac Electrophysiology 115
Stefania Fresca, Luca Dede and Andrea Manzoni

6.1 Overview of Cardiac Physiology 115

6.1.1 Atrial Tachycardia and Atrial Fibrillation 117

6.1.2 Mathematical Models for Cardiac Electrophysiology 118

6.2 Reduced Order Modeling 121

6.2.1 Problem Formulation 123

6.2.2 Nonlinear Dimensionality Reduction 123

6.3 Decreasing Complexity in Cardiac Electrophysiology 124

6.3.1 POD-Enhanced Deep Learning-Based ROMs 125

6.3.1.1 POD-DL-ROM Architecture and Algorithms 128

6.4 Numerical Results 130

6.4.1 Test 1: Two-Dimensional Slab with Figure of Eight Reentry 131

6.4.2 Test 2: Three-Dimensional Left Ventricle Geometry 133

6.4.3 Test 3: Left Atrium Surface by Varying the Stimuli Location 135

6.4.4 Test 4: Reentry Breakup 137

6.5 Conclusions 139

Author Biographies 140

References 140

7 The Potential of Microbiome Big Data in Precision Medicine: Predicting Outcomes Through Machine Learning 149
Silvia Turroni and Simone Rampelli

7.1 The Gut Microbiome: A Major Player in Human Physiology and Pathophysiology 149

7.2 Machine Learning Applied to Microbiome Research 151

7.2.1 Case Study 1: Obesity 151

7.2.2 Case Study 2: Cancer 153

7.2.3 Case Study 3: Personalized Nutrition 154

7.2.4 Case Study 4: Exploiting the Meta-Community Theory for New Machine Learning Approaches 155

7.3 Conclusions and Perspectives 155

Author Biographies 156

References 156

8 Predictive Patient Stratification Using Artificial Intelligence and Machine Learning 161
Thanh-Phuong Nguyen, Thanh T. Giang, Quang T. Pham and Dang H. Tran

8.1 Overview of Artificial Intelligence for Patient Stratification 161

8.2 A RPCA and MKL Combination Model for Patient Stratification 164

8.2.1 Robust Principal Component Analysis 164

8.2.2 Dimensionality Reduction and Features Extraction Based on RPCA 166

8.2.3 Predictive Model Construction Based on Multiple Kernel Learning 168

8.2.4 Materials 169

8.2.4.1 Cancer Patient Datasets 169

8.2.4.2 Alzheimer Disease Patient Datasets 170

8.2.5 Experiment Design 171

8.2.5.1 Experiment of Stratifying Cancer Patients 171

8.2.5.2 Experiment of Stratifying Alzheimer Disease Patients 171

8.2.6 Results and Discussions 171

8.2.6.1 Application of Stratifying Cancer Patients 172

8.2.7 Application of Stratifying Alzheimer Disease Patients 174

8.3 Conclusion 175

Author Biographies 175

References 176

9 Hybrid Data-Driven and Numerical Modeling of Articular Cartilage 181
Seyed Shayan Sajjadinia, Bruno Carpentieri and Gerhard A. Holzapfel

9.1 Introduction 181

9.2 Knee and Cartilage 182

9.2.1 Main Joint Substructures 182

9.2.2 Load-Bearing Cartilage Phases 183

9.3 Physics-Based Modeling 185

9.3.1 Numerical Modeling 185

9.3.2 Constitutive Modeling 188

9.4 AI-Enhanced Modeling 191

9.4.1 Deep Learning 191

9.4.2 Surrogate Modeling 192

9.5 Discussion and Conclusion 194

Author Biographies 194

References 195

10 A Hybrid of Differential Evolution and Minimization of Metabolic Adjustment for Succinic and Ethanol Production 205
Zhang N. Hor, Mohd S. Mohamad, Yee W. Choon, Muhammad A. Remli and Hairudin A. Majid

10.1 Introduction 205

10.2 Method 206

10.2.1 Differential Evolution (DE) 206

10.2.2 Mutation 206

10.2.3 Crossover 207

10.2.4 Selection 208

10.2.5 Minimization of Metabolic Adjustment 208

10.2.6 A Hybrid of Differential Evolution and Minimization of Metabolic Adjustment 209

10.3 Experiments and Discussion 209

10.3.1 Dataset 209

10.3.2 Parameter Setting 209

10.3.3 Experimental Results 210

10.3.4 Comparative Analysis 214

10.4 Conclusion 214

Acknowledgment 215

Author Bibliographies 215

References 216

11 Analysis Pipelines and a Platform Solution for Next-Generation Sequencing Data 219
Víctor Duarte, Alesandro Gómez and Juan M. Corchado

11.1 Introduction 219

11.2 NGS Data Analysis Pipeline and State of the Art Tools 220

11.2.1 Quality Assessment 220

11.2.2 Alignment 221

11.2.3 Post-alignment and pre-variant Calling Processing 222

11.2.4 Variant Calling 223

11.2.5 Variant Annotation 228

11.3 Nanopore Sequencing Data Analysis 229

11.3.1 Base-Calling 230

11.3.2 Quality Control and Preprocessing 230

11.3.3 Error Correction 231

11.3.4 Alignment 231

11.3.5 Variant Calling 231

11.4 Machine Learning Approaches in Variant Calling 232

11.5 Next-Generation Sequencing Data Analysis Frameworks 233

11.6 DeepNGS 235

11.6.1 Pipeline 235

11.6.2 DeepNGS Main Features 236

11.6.2.1 Power and Speed 236

11.6.2.2 Optimized Workflow 236

11.6.2.3 Intuitive Design and Interactive Charts 237

11.6.2.4 Extended Information 237

11.6.2.5 Artificial Intelligence and Machine Learning 237

11.7 Conclusions 240

Author Biographies 241

References 241

12 Artificial Intelligence: From Drug Discovery to Clinical Pharmacology 253
Paola Lecca

12.1 Artificial Intelligence and the Druggable Genome 253

12.2 Feature-Based Methods 257

12.3 Similarity/Distance-Based Methods 257

12.4 Matrix Factorization 258

12.4.1 Causal K-Nearest-Neighborhood 261

12.4.2 Causal Random Forests 263

12.4.3 Causal Support Vector Machine 264

12.5 Opportunities and Challenges 265

Author Biography 266

References 266

13 Using AI to Steer Brain Regeneration: The Enhanced Regenerative Medicine Paradigm 273
Gabriella Panuccio, Narayan P. Subramaniyam, Angel Canal-Alonso, Juan M. Corchado and Carlo Ierna

13.1 The Challenge of Brain Regeneration 273

13.2 The Enhanced Regenerative Medicine Paradigm 274

13.3 The Case of Epilepsy 276

13.4 AI to Understand Epilepsy 279

13.4.1 Commonly Applied Learning Algorithms for Basic Neuroscience and Clinical Application in Epilepsy 282

13.4.2 Seizure and Epilepsy Type Classification 284

13.4.3 Seizure Onset Zone Localization 284

13.4.4 Seizure Detection 285

13.4.5 Seizure Prediction 285

13.4.6 Signal Feature Extraction for Seizure Detection and Prediction 288

13.4.7 Network Interactions and Evolving Dynamics in the Epileptic Brain: The Eye of AI 290

13.5 Artificial Intelligence to Guide Graft-Host Dynamics in Epilepsy 292

13.6 Challenges and Limitations 294

13.6.1 From AI to Explainable AI 295

13.7 A Philosophical Perspective on Enhanced Brain Regeneration 297

Acknowledgments 299

Acronyms 299

Author Biographies 300

References 300

14 Towards Better Ways to Assess Predictive Computing in Medicine: On Reliability, Robustness, and Utility 309
Federico Cabitza and Andrea Campagner

14.1 Introduction 309

14.2 On Ground Truth Reliability 311

14.2.1 Weighted Reliability 314

14.2.2 Example Application 316

14.3 On Utility Metrics to Evaluate ML Performance 318

14.3.1 Weighted Utility 318

14.3.2 Example Application 321

14.4 On the Replicability of Clinical ML Models 322

14.4.1 Dataset Size 323

14.4.2 Dataset Similarity 325

14.4.3 Meta-Validation Procedure 325

14.4.4 Example Application 328

14.5 Conclusions and Future Outlook 331

Author Biographies 332

References 333

15 Legal Aspects of AI in the Biomedical Field. The Role of Interpretable Models 339
Chiara Gallese

15.1 Introduction 339

15.2 Data Protection 340

15.3 Transparency Principle 343

15.3.1 Right of Explanation 343

15.3.2 Right of Information 348

15.3.3 Informed Consent Requirements 349

15.4 Accountability Principle 350

15.5 Non-discrimination Principle and Biases 351

15.6 High-Risk Systems and Human Oversight 353

15.7 Additional Requirements of the AI Act Proposal 354

15.8 Interpretability as a Standard 355

15.9 Conclusion 358

Author Biography 358

References 359

16 The Long Path to Usable AI 363
Barbara Di Camillo, Enrico Longato, Erica Tavazzi and Martina Vettoretti

16.1 Promises and Challenges of Artificial Intelligence in Healthcare 363

16.2 Deployment of Usable Artificial Intelligence Models 367

16.2.1 Case Study: Predicting the Cardiovascular Complications of Diabetes via a Deep Learning Approach 368

16.3 Potential and Challenges of Employing Longitudinal Clinical Data in AI 375

16.3.1 Case Study: Modeling the Progression of Amyotrophic Lateral Sclerosis Through a Dynamic Bayesian Network 378

16.3.2 Case Study: Investigating Amyotrophic Lateral Sclerosis Progression Trajectories Leveraging Process Mining 381

16.4 Enhancing the Applicability of AI Predictive Models by a Combined Model Approach: A Case Study on T2D Onset Prediction 386

16.4.1 The Problem of Type 2 Diabetes Prediction 386

16.4.2 Potential Applications of T2D Predictive Models 387

16.4.3 Barriers to the Adoption of T2D Predictive Models 387

16.4.4 Addressing Practical Issues by Combining Multiple T2D Predictive Models 388

16.4.5 The Combined Model Achieves High Prediction Performance with High Coverage 390

16.5 Conclusions and Future Outlook 391

Author Biography 392

References 393

Index 399